Klinique Financial Statements From 2010 to 2024
| KLINIQ Stock | 31.50 0.75 2.44% |
Check Klinique Med financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Klinique Med's main balance sheet or income statement drivers, such as , as well as many indicators such as . Klinique financial statements analysis is a perfect complement when working with Klinique Med Valuation or Volatility modules.
Klinique |
The Klinique Med Company Return On Asset Analysis
Klinique Med's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Klinique Med Return On Asset | 0.12 |
Most of Klinique Med's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, The Klinique Med is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, The Klinique Med has a Return On Asset of 0.12. This is 88.99% lower than that of the Consumer Cyclical sector and 95.92% lower than that of the Personal Services industry. The return on asset for all Thailand stocks is 185.71% lower than that of the firm.
Klinique Med Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Klinique Med's current stock value. Our valuation model uses many indicators to compare Klinique Med value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Klinique Med competition to find correlations between indicators driving Klinique Med's intrinsic value. More Info.The Klinique Med is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.13 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for The Klinique Med is roughly 7.93 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Klinique Med by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Klinique Med's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Klinique Med Financial Statements
Klinique Med stakeholders use historical fundamental indicators, such as Klinique Med's revenue or net income, to determine how well the company is positioned to perform in the future. Although Klinique Med investors may analyze each financial statement separately, they are all interrelated. For example, changes in Klinique Med's assets and liabilities are reflected in the revenues and expenses on Klinique Med's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in The Klinique Med. Please read more on our technical analysis and fundamental analysis pages.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Klinique Stock
Klinique Med financial ratios help investors to determine whether Klinique Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Klinique with respect to the benefits of owning Klinique Med security.